217 related articles for article (PubMed ID: 27493260)
21. Discordant Metabolic Response on 18F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma.
Hao W; Li Y; Du B; Li X
Clin Nucl Med; 2022 Feb; 47(2):133-136. PubMed ID: 35006108
[TBL] [Abstract][Full Text] [Related]
22. FDG avidity and PET/CT patterns in primary gastric lymphoma.
Radan L; Fischer D; Bar-Shalom R; Dann EJ; Epelbaum R; Haim N; Gaitini D; Israel O
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1424-30. PubMed ID: 18418594
[TBL] [Abstract][Full Text] [Related]
23. Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.
Mehta A; Muthukrishnan A
Hell J Nucl Med; 2011; 14(2):186-7. PubMed ID: 21761029
[No Abstract] [Full Text] [Related]
24. Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
Sharma P; Dwary AD; Khan EM
Clin Nucl Med; 2017 Oct; 42(10):807-808. PubMed ID: 28806259
[TBL] [Abstract][Full Text] [Related]
25. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U
Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
[TBL] [Abstract][Full Text] [Related]
26. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
27. Multiple intraabdominal purulent collections demonstrated on FDG PET/CT in staging of non-Hodgkin lymphoma.
Tow J; Loh H; Bui C; Fuller S; Mansberg R
Clin Nucl Med; 2012 Feb; 37(2):210-3. PubMed ID: 22228357
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.
Watanabe Y; Suefuji H; Hirose Y; Kaida H; Suzuki G; Uozumi J; Ogo E; Miura M; Takasu K; Miyazaki K; Nakahara K; Ishibashi M; Okamura T; Ohshima K; Hayabuchi N
Int J Hematol; 2013 Jan; 97(1):43-9. PubMed ID: 23212465
[TBL] [Abstract][Full Text] [Related]
29. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
30. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
[TBL] [Abstract][Full Text] [Related]
31. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
Malibari N; Hickeson M; Lisbona R
PET Clin; 2015 Jul; 10(3):311-26. PubMed ID: 26099669
[TBL] [Abstract][Full Text] [Related]
32. Mucosa-associated lymphoid tissue lymphoma studied with FDG-PET: a comparison with CT and endoscopic findings.
Enomoto K; Hamada K; Inohara H; Higuchi I; Tomita Y; Kubo T; Hatazawa J
Ann Nucl Med; 2008 May; 22(4):261-7. PubMed ID: 18535876
[TBL] [Abstract][Full Text] [Related]
33. The role of [18F]FDG PET/CT for gastric cancer management.
Salmanoglu E
Nucl Med Rev Cent East Eur; 2021; 24(2):99-103. PubMed ID: 34382674
[TBL] [Abstract][Full Text] [Related]
34. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Shen YY; Kao A; Yen RF
Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Positron Emission Tomography/Computed Tomography in Gastric Mucosa-associated Lymphoid Tissue Lymphoma.
Hwang JW; Jee SR; Lee SH; Kim JH; Seol SY; Lee SM
Korean J Gastroenterol; 2016 Apr; 67(4):183-8. PubMed ID: 27112244
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
Lim SM; Kim H; Kang B; Kim HS; Rha SY; Noh SH; Hyung WJ; Cheong JH; Kim HI; Chung HC; Yun M; Cho A; Jung M
Ann Nucl Med; 2016 May; 30(4):279-86. PubMed ID: 26837515
[TBL] [Abstract][Full Text] [Related]
37. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer.
Kaneko Y; Murray WK; Link E; Hicks RJ; Duong C
J Nucl Med; 2015 Apr; 56(4):523-9. PubMed ID: 25745094
[TBL] [Abstract][Full Text] [Related]
38. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
39. Isolated Small Bowel Metastasis From Gastric Cancer Detected by 18F-FDG PET/CT.
Fan Q; Su M
Clin Nucl Med; 2019 Oct; 44(10):840-841. PubMed ID: 31283609
[TBL] [Abstract][Full Text] [Related]
40. The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
Serrano OK; Love C; Goldman I; Huang K; Ng N; Abraham T; Da Silva R; Friedmann P; Libutti SK; Kennedy TJ
J Surg Oncol; 2016 May; 113(6):640-6. PubMed ID: 27115836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
